Differential effects of soluble epoxide hydrolase inhibition and CYP2J2 overexpression on postischemic cardiac function in aged mice

Prostaglandins and Other Lipid Mediators

Volumn 104-105, Issue , 2013, Pages 8-17

  Chaudhary, Ketul R ^a   Zordoky, Beshay N M ^a   Edin, Matthew L ^b   Alsaleh, Nasser ^a   El Kadi, Ayman O S ^a   Zeldin, Darryl C ^b   Seubert, John M ^a  

^a UNIVERSITY OF ALBERTA   (Canada)

^b NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES   (United States)

Author keywords

Aging; Cytochrome P450; Epoxyeicosatrienoic acids; Ischemia reperfusion injury; Leukotoxin diol; Soluble epoxide hydrolase inhibitor

Indexed keywords

CYTOCHROME P450 2J2; EPOXIDE HYDROLASE; EPOXYICOSATRIENOIC ACID; ICOSANOID; PHOSPHOPROTEIN PHOSPHATASE 2A;

AGED; CONFERENCE PAPER; ENZYME ACTIVITY; ENZYME INHIBITION; HEART FUNCTION; HEART MUSCLE ISCHEMIA; HEART MUSCLE RELAXATION; HEART PROTECTION; IMMUNOBLOTTING; MOUSE; NONHUMAN; OXIDATIVE STRESS; PROTEIN EXPRESSION; REPERFUSION INJURY; TANDEM MASS SPECTROMETRY;

8,11,14-EICOSATRIENOIC ACID; AGE FACTORS; ANIMALS; BENZOATES; CARDIOTONIC AGENTS; CELLS, CULTURED; CYTOCHROME P-450 ENZYME SYSTEM; EPOXIDE HYDROLASES; FEMALE; GENE EXPRESSION REGULATION; HEART; MALE; MICE; MICE, KNOCKOUT; MYOCARDIAL REPERFUSION INJURY; MYOCYTES, CARDIAC; ORGAN CULTURE TECHNIQUES; OXIDATIVE STRESS; PROTEIN PHOSPHATASE 2; STEARIC ACIDS; UREA;

EID: 84879696058     PISSN: 10988823     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.prostaglandins.2012.08.001     Document Type: Conference Paper

References (47)

1. K.R. Chaudhary, S.N. Batchu, D. Das, M.R. Suresh, J.R. Falck, and J.P. Graves Role of B-type natriuretic peptide in epoxyeicosatrienoic acid-mediated improved post-ischaemic recovery of heart contractile function Cardiovasc Res 83 2009 362 370
2. S. Wu, C.R. Moomaw, K.B. Tomer, J.R. Falck, and D.C. Zeldin Molecular cloning and expression of CYP2J2, a human cytochrome P450 arachidonic acid epoxygenase highly expressed in heart J Biol Chem 271 1996 3460 3468 (Pubitemid 26065653)
3. J.M. Seubert, D.C. Zeldin, K. Nithipatikom, and G.J. Gross Role of epoxyeicosatrienoic acids in protecting the myocardium following ischemia/reperfusion injury Prostaglandins Other Lipid Mediat 82 2007 50 59 (Pubitemid 44880163)
4. A.A. Spector, and A.W. Norris Action of epoxyeicosatrienoic acids on cellular function Am J Physiol Cell Physiol 292 2007 C996 C1012 (Pubitemid 46442641)
5. X. Fang, N.L. Weintraub, C.L. Oltman, L.L. Stoll, T.L. Kaduce, and S. Harmon Human coronary endothelial cells convert 14,15-EET to a biologically active chain-shortened epoxide Am J Physiol Heart Circ Physiol 283 2002 H2306 H2314 (Pubitemid 35345934)
6. X. Fang, N.L. Weintraub, R.B. McCaw, S. Hu, S.D. Harmon, and J.B. Rice Effect of soluble epoxide hydrolase inhibition on epoxyeicosatrienoic acid metabolism in human blood vessels Am J Physiol Heart Circ Physiol 287 2004 H2412 H2420 (Pubitemid 39557109)
7. K.R. Schmelzer, L. Kubala, J.W. Newman, I.H. Kim, J.P. Eiserich, and B.D. Hammock Soluble epoxide hydrolase is a therapeutic target for acute inflammation Proc Natl Acad Sci USA 102 2005 9772 9777 (Pubitemid 40993644)
8. M. Decker, M. Arand, and A. Cronin Mammalian epoxide hydrolases in xenobiotic metabolism and signalling Arch Toxicol 83 2009 297 318
9. + channels and p42/p44 MAPK pathway Circ Res 95 2004 506 514 (Pubitemid 39180931)
10. J.M. Seubert, C.J. Sinal, J. Graves, L.M. DeGraff, J.A. Bradbury, and C.R. Lee Role of soluble epoxide hydrolase in postischemic recovery of heart contractile function Circ Res 99 2006 442 450 (Pubitemid 44253701)
11. G.J. Gross, J.E. Baker, A. Hsu, H.E. Wu, J.R. Falck, and K. Nithipatikom Evidence for a role of opioids in epoxyeicosatrienoic acid-induced cardioprotection in rat hearts Am J Physiol Heart Circ Physiol 298 2010 H2201 H2207
12. K.R. Chaudhary, M. Abukhashim, S.H. Hwang, B.D. Hammock, and J.M. Seubert Inhibition of soluble epoxide hydrolase by trans-4- [4-(3-adamantan-1-yl- ureido)-cyclohexyloxy]-benzoic acid is protective against ischemia-reperfusion injury J Cardiovasc Pharmacol 55 2010 67 73
13. A. Motoki, M.J. Merkel, W.H. Packwood, Z. Cao, L. Liu, and J. Iliff Soluble epoxide hydrolase inhibition and gene deletion are protective against myocardial ischemia-reperfusion injury in vivo Am J Physiol Heart Circ Physiol 295 2008 H2128 H2134
14. A. Dhanasekaran, S.K. Gruenloh, J.N. Buonaccorsi, R. Zhang, G.J. Gross, and J.R. Falck Multiple antiapoptotic targets of the PI3K/Akt survival pathway are activated by epoxyeicosatrienoic acids to protect cardiomyocytes from hypoxia/anoxia Am J Physiol Heart Circ Physiol 294 2008 H724 H735 (Pubitemid 351253284)
15. Y.X. Wang, X.J. Zeng, L.Q. Lu, L.Q. Ma, D.Q. Jiang, and J. Mu Effects of 11, 12-epoxyeicosatrienoic acid preconditioning and postconditioning on Ca(2+)-handling proteins in myocardial ischemia/reperfusion injury in rats Zhongguo Yi Xue Ke Xue Yuan Xue Bao 29 2007 787 791 (Pubitemid 351188200)
16. M.L. Edin, Z. Wang, J.A. Bradbury, J.P. Graves, F.B. Lih, and L.M. DeGraff Endothelial expression of human cytochrome P450 epoxygenase CYP2C8 increases susceptibility to ischemia-reperfusion injury in isolated mouse heart FASEB J 25 2011 3436 3447
17. S. Bodiga, R. Zhang, D.E. Jacobs, B.T. Larsen, A. Tampo, and V.L. Manthati Protective actions of epoxyeicosatrienoic acid: dual targeting of cardiovascular PI3K and KATP channels J Mol Cell Cardiol 46 2009 978 988
18. K.R. Chaudhary, H.E. El-Sikhry, and J.M. Seubert Mitochondria and the aging heart J Geriatr Cardiol 8 2011 159 167
19. M. Liu, P. Zhang, M. Chen, W. Zhang, L. Yu, and X.C. Yang Aging might increase myocardial ischemia/reperfusion-induced apoptosis in humans and rats Age (Dordr) 34 2012 621 632
20. J. Mariani, R. Ou, M. Bailey, M. Rowland, P. Nagley, and F. Rosenfeldt Tolerance to ischemia and hypoxia is reduced in aged human myocardium J Thorac Cardiovasc Surg 120 2000 660 667
21. K. Boengler, R. Schulz, and G. Heusch Loss of cardioprotection with ageing Cardiovasc Res 83 2009 247 261
22. S.N. Batchu, E. Law, D.R. Brocks, J.R. Falck, and J.M. Seubert Epoxyeicosatrienoic acid prevents postischemic electrocardiogram abnormalities in an isolated heart model J Mol Cell Cardiol 46 2009 67 74
23. C.P. Baines, J. Zhang, G.W. Wang, Y.T. Zheng, J.X. Xiu, and E.M. Cardwell Mitochondrial PKCepsilon and MAPK form signaling modules in the murine heart: enhanced mitochondrial PKCepsilon-MAPK interactions and differential MAPK activation in PKCepsilon-induced cardioprotection Circ Res 90 2002 390 397 (Pubitemid 34633907)
24. M.E. Aboutabl, B.N. Zordoky, and A.O. El-Kadi 3-methylcholanthrene and benzo(a)pyrene modulate cardiac cytochrome P450 gene expression and arachidonic acid metabolism in male Sprague Dawley rats Br J Pharmacol 158 2009 1808 1819
25. I. Dalle-Donne, R. Rossi, D. Giustarini, A. Milzani, and R. Colombo Protein carbonyl groups as biomarkers of oxidative stress Clin Chim Acta 329 2003 23 38 (Pubitemid 36187411)
26. J.N. Peart, L. See Hoe, S. Pepe, P. Johnson, and J.P. Headrick Opposing effects of age and calorie restriction on molecular determinants of myocardial ischemic tolerance Rejuvenation Res 15 2012 59 70
27. P. Abete, N. Ferrara, A. Cioppa, P. Ferrara, S. Bianco, and C. Calabrese Preconditioning does not prevent postischemic dysfunction in aging heart J Am Coll Cardiol 27 1996 1777 1786 (Pubitemid 26198034)
28. Q. Dai, G.P. Escobar, K.W. Hakala, J.M. Lambert, S.T. Weintraub, and M.L. Lindsey The left ventricle proteome differentiates middle-aged and old left ventricles in mice J Proteome Res 7 2008 756 765 (Pubitemid 351294038)
29. D.A. Thompson, and B.D. Hammock Dihydroxyoctadecamonoenoate esters inhibit the neutrophil respiratory burst J Biosci 32 2007 279 291 (Pubitemid 46708725)
30. + channels contribute to 11,12-epoxyeicosatrienoic acid analog mediated mesenteric arterial relaxation Prostaglandins Other Lipid Mediat 83 2007 50 61 (Pubitemid 46149401)
31. + channels Microcirculation 15 2008 137 150 (Pubitemid 351228638)
32. D. Schulman, D.S. Latchman, and D.M. Yellon Effect of aging on the ability of preconditioning to protect rat hearts from ischemia-reperfusion injury Am J Physiol Heart Circ Physiol 281 2001 H1630 H1636
33. K. Boengler, I. Konietzka, A. Buechert, Y. Heinen, D. Garcia-Dorado, and G. Heusch Loss of ischemic preconditioning's cardioprotection in aged mouse hearts is associated with reduced gap junctional and mitochondrial levels of connexin 43 Am J Physiol Heart Circ Physiol 292 2007 H1764 H1769 (Pubitemid 46572399)
34. M.F. Sisemore, J. Zheng, J.C. Yang, D.A. Thompson, C.G. Plopper, and G.A. Cortopassi Cellular characterization of leukotoxin diol-induced mitochondrial dysfunction Arch Biochem Biophys 392 2001 32 37 (Pubitemid 32721611)
35. A. Fukushima, M. Hayakawa, S. Sugiyama, M. Ajioka, T. Ito, and T. Satake Cardiovascular effects of leukotoxin (9, 10-epoxy-12-octadecenoate) and free fatty acids in dogs Cardiovasc Res 22 1988 213 218 (Pubitemid 18075572)
36. J.R. Stimers, M. Dobretsov, S.L. Hastings, A.R. Jude, and D.F. Grant Effects of linoleic acid metabolites on electrical activity in adult rat ventricular myocytes Biochim Biophys Acta 1438 1999 359 368 (Pubitemid 29301724)
37. M.F. Moghaddam, D.F. Grant, J.M. Cheek, J.F. Greene, K.C. Williamson, and B.D. Hammock Bioactivation of leukotoxins to their toxic diols by epoxide hydrolase Nat Med 3 1997 562 566 (Pubitemid 27198657)
38. J. Zheng, C.G. Plopper, J. Lakritz, D.H. Storms, and B.D. Hammock Leukotoxin-diol: a putative toxic mediator involved in acute respiratory distress syndrome Am J Respir Cell Mol Biol 25 2001 434 438 (Pubitemid 33037675)
39. A. Dudda, G. Spiteller, and F. Kobelt Lipid oxidation products in ischemic porcine heart tissue Chem Phys Lipids 82 1996 39 51 (Pubitemid 26312859)
40. M.D. Harrell, and J.R. Stimers Differential effects of linoleic acid metabolites on cardiac sodium current J Pharmacol Exp Ther 303 2002 347 355
41. Y.F. Xiao, J.X. Kang, J.P. Morgan, and A. Leaf Blocking effects of polyunsaturated fatty acids on Na+ channels of neonatal rat ventricular myocytes Proc Natl Acad Sci USA 92 1995 11000 11004
42. S. Viswanathan, B.D. Hammock, J.W. Newman, P. Meerarani, M. Toborek, and B. Hennig Involvement of CYP 2C9 in mediating the proinflammatory effects of linoleic acid in vascular endothelial cells J Am Coll Nutr 22 2003 502 510 (Pubitemid 38010016)
43. J.H. Moran, L.A. Mitchell, J.A. Bradbury, W. Qu, D.C. Zeldin, and R.G. Schnellmann Analysis of the cytotoxic properties of linoleic acid metabolites produced by renal and hepatic P450s Toxicol Appl Pharmacol 168 2000 268 279
44. D.J. Granville, B. Tashakkor, C. Takeuchi, A.B. Gustafsson, C. Huang, and M.R. Sayen Reduction of ischemia and reperfusion-induced myocardial damage by cytochrome P450 inhibitors Proc Natl Acad Sci USA 101 2004 1321 1326 (Pubitemid 38182687)
45. L. Liu, C. Chen, W. Gong, Y. Li, M.L. Edin, and D.C. Zeldin Epoxyeicosatrienoic acids attenuate reactive oxygen species level, mitochondrial dysfunction, caspase activation, and apoptosis in carcinoma cells treated with arsenic trioxide J Pharmacol Exp Ther 339 2011 451 463
46. B. Yang, L. Graham, S. Dikalov, R.P. Mason, J.R. Falck, and J.K. Liao Overexpression of cytochrome P450 CYP2J2 protects against hypoxia-reoxygenation injury in cultured bovine aortic endothelial cells Mol Pharmacol 60 2001 310 320 (Pubitemid 32678296)
47. V. Janssens, and J. Goris Protein phosphatase 2A: a highly regulated family of serine/threonine phosphatases implicated in cell growth and signalling Biochem J 353 2001 417 439 (Pubitemid 32158309)